Kadcyla Powder for Concentrate for Solution for Infusion 160 mg/8 ml

Kadcyla 160 mg powder for concentrate for solution for infusion. One vial of powder for concentrate for solution for infusion contains 160 mg of Trastuzumab emtansine. After reconstitution, one vial of 8 mL solution contains 20 mg/mL of Trastuzumab emtansine. * Trastuzumab emtansine is an antibody-drug conjugate that contains trastuzumab, a humanised IgG1 monoclonal antibody produced by mammalian (Chinese hamster ovary) cell suspension culture, covalently linked to DM1, a microtubule inhibitor, via the stable thioether linker MCC (4-[N-maleimidomethyl] cyclohexane-1-carboxylate)